Logo image of CRAV.PA

CA ATLANTIQUE VENDEE-CCI (CRAV.PA) Stock Analyst Earnings Estimates

EPA:CRAV - Euronext Paris - Matif - FR0000185506 - Common Stock - Currency: EUR

100  0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
CRAV.PA revenue by date.CRAV.PA revenue by date.
549.1M
15.77%
606.711M
10.49%
540.074M
-10.98%
EBITDA
YoY % growth
CRAV.PA ebitda by date.CRAV.PA ebitda by date.
N/AN/AN/A
EBIT
YoY % growth
CRAV.PA ebit by date.CRAV.PA ebit by date.
N/AN/AN/A
Operating Margin
CRAV.PA operating margin by date.CRAV.PA operating margin by date.
N/AN/AN/A
EPS
YoY % growth
CRAV.PA eps by date.CRAV.PA eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
CRAV.PA Yearly EPS VS EstimatesCRAV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
300.971M
2.15%
%
Q4 2023
Q2Q % growth
245.442M
-8.40%
%
Q2 2023
Q2Q % growth
294.632M
-13.50%
%
Q4 2022
Q2Q % growth
267.938M
-1.51%
%
Q2 2022
Q2Q % growth
340.609M
22.86%
%
Q4 2021
Q2Q % growth
272.049M
9.12%
%
Q2 2021
Q2Q % growth
277.231M
23.14%
%
Q4 2020
Q2Q % growth
249.302M
2.39%
%
Q2 2020
Q2Q % growth
225.13M
-15.00%
%
CRAV.PA Yearly Revenue VS EstimatesCRAV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A